財務情報
- Market Capitalization 13.18 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4578 | ESLA Estrella Immunopharma, Inc. - Common Stock | 0.31 USD | -6.06% | -24.39% | -54.41% | -81.21% | 13.48 M USD | ||
| 4583 | LPCN Lipocine Inc. - Common Stock | 1.62 USD | -2.41% | -45.27% | -26.36% | -44.14% | 13.36 M USD | ||
| 4587 | CLRB Cellectar Biosciences, Inc. - Common Stock | 1.39 USD | -2.80% | -8.55% | -39.83% | -55.73% | 13.14 M USD | ||
| 4590 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 8.04 USD | -8.74% | -12.61% | -27.63% | +37.44% | 13.02 M USD |